Form S-3 COGNITION THERAPEUTICS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall Street rises on revived AI momentum as earnings season picks up
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- S&P Global explores potential separation of Capital IQ business
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
Cognition Therapeutics establishes $75 million stock offering program
December 18, 2025 4:22 PM ESTCognition Therapeutics Inc. (NASDAQ: CGTX) entered into an at-the-market equity offering agreement with Jefferies LLC on December 18, 2024, according to a company filing.
Under the sales agreement, Cognition Therapeutics may sell up to $75 million of its common stock through Jefferies, which will... More
Cognition Therapeutics, Inc. (CGTX) files $300M mixed shelf
December 18, 2025 4:09 PM ESTCognition Therapeutics, Inc. (NASDAQ: CGTX) has filed $300,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
Subscription Rights



